发明授权
- 专利标题： Prostaglandin endoperoxide H synthase biosynthesis inhibitors
- 专利标题（中）： 前列腺素内过氧化物H合成酶生物合成抑制剂
-
申请号： US10417959申请日： 2003-04-17
-
公开(公告)号： US07001895B2公开(公告)日： 2006-02-21
- 发明人: Lawrence A. Black , Anwer Basha , Teodozyj Kolasa , Michael E. Kort , Huaqing Liu , Catherine M. McCarty , Meena Patel , Jeffrey J. Rohde , Michael J. Coghlan , Andrew O. Stewart
- 申请人： Lawrence A. Black , Anwer Basha , Teodozyj Kolasa , Michael E. Kort , Huaqing Liu , Catherine M. McCarty , Meena Patel , Jeffrey J. Rohde , Michael J. Coghlan , Andrew O. Stewart
- 申请人地址： US IL Abbott Park
- 专利权人： Abbott Laboratories
- 当前专利权人： Abbott Laboratories
- 当前专利权人地址： US IL Abbott Park
- 代理商 Portia Chen
- 主分类号： A61K31/50
- IPC分类号： A61K31/50 ; A61K31/675 ; C07D237/16
摘要：
The present invention describes pyridazinone compounds of formula I which are cyclooxygenase (COX) inhibitors, and in particular, are selective inhibitors of cyclooxygenase-2 (COX-2). COX-2 is the inducible isoform associated with inflammation, as opposed to the constitutive isoform, cyclooxygenase-1 (COX-1) which is an important “housekeeping” enzyme in many tissues, including the gastrointestinal (GI) tract and the kidneys. The selectivity of these compounds for COX-2 minimizes the unwanted GI and renal side-effects seen with currently marketed non-steroidal anti-inflammatory drugs (NSAIDs).
公开/授权文献
信息查询
